Deventer A, Stevens C, Stewart A, Hobbs J
Clin Microbiol Rev. 2024; 37(4):e0010624.
PMID: 39364999
PMC: 11629620.
DOI: 10.1128/cmr.00106-24.
Rodrigues M, Sabaeifard P, Yildiz M, Lyon A, Coughlin L, Ahmed S
Cell Host Microbe. 2024; 32(3):396-410.e6.
PMID: 38359828
PMC: 10942764.
DOI: 10.1016/j.chom.2024.01.012.
Furfaro L, Payne M, Chang B
PLoS One. 2020; 15(6):e0235002.
PMID: 32574197
PMC: 7310703.
DOI: 10.1371/journal.pone.0235002.
Campo C, Martinez M, Otero J, Rincon G
Biomedica. 2019; 39(4):689-698.
PMID: 31860180
PMC: 7363344.
DOI: 10.7705/biomedica.4514.
Six A, Krajangwong S, Crumlish M, Zadoks R, Walker D
Virulence. 2019; 10(1):600-609.
PMID: 31230520
PMC: 6592362.
DOI: 10.1080/21505594.2019.1631660.
No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia.
Yayan J, Ghebremedhin B, Rasche K
Int J Med Sci. 2015; 12(12):980-6.
PMID: 26664260
PMC: 4661297.
DOI: 10.7150/ijms.13203.
DNA microarray-based typing of Streptococcus agalactiae isolates.
Nitschke H, Slickers P, Muller E, Ehricht R, Monecke S
J Clin Microbiol. 2014; 52(11):3933-43.
PMID: 25165085
PMC: 4313228.
DOI: 10.1128/JCM.02411-14.
Characterization of multi-drug tolerant persister cells in Streptococcus suis.
Willenborg J, Willms D, Bertram R, Goethe R, Valentin-Weigand P
BMC Microbiol. 2014; 14:120.
PMID: 24885389
PMC: 4040513.
DOI: 10.1186/1471-2180-14-120.
Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.
Longtin J, Vermeiren C, Shahinas D, Tamber G, McGeer A, Low D
Antimicrob Agents Chemother. 2011; 55(6):2983-5.
PMID: 21383092
PMC: 3101384.
DOI: 10.1128/AAC.01243-10.
Cadaverine suppresses persistence to carboxypenicillins in Pseudomonas aeruginosa PAO1.
Manuel J, Zhanel G, de Kievit T
Antimicrob Agents Chemother. 2010; 54(12):5173-9.
PMID: 20855735
PMC: 2981224.
DOI: 10.1128/AAC.01751-09.
Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany.
Fluegge K, Supper S, Siedler A, Berner R
Antimicrob Agents Chemother. 2004; 48(11):4444-6.
PMID: 15504878
PMC: 525390.
DOI: 10.1128/AAC.48.11.4444-4446.2004.
Antibiotic resistance patterns of group B streptococcal clinical isolates.
Simoes J, Aroutcheva A, Heimler I, Faro S
Infect Dis Obstet Gynecol. 2004; 12(1):1-8.
PMID: 15460188
PMC: 1784590.
DOI: 10.1080/10647440410001722269.
Six-month multicenter study on invasive infections due to group B streptococci in Argentina.
Lopardo H, Vidal P, Jeric P, Centron D, Paganini H, Facklam R
J Clin Microbiol. 2003; 41(10):4688-94.
PMID: 14532204
PMC: 254350.
DOI: 10.1128/JCM.41.10.4688-4694.2003.
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
Betriu C, Culebras E, Gomez M, Rodriguez-Avial I, Sanchez B, Agreda M
Antimicrob Agents Chemother. 2003; 47(3):1112-4.
PMID: 12604549
PMC: 149330.
DOI: 10.1128/AAC.47.3.1112-1114.2003.
High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.
Hsueh P, Teng L, Lee L, Ho S, Yang P, Luh K
Antimicrob Agents Chemother. 2001; 45(11):3205-8.
PMID: 11600380
PMC: 90806.
DOI: 10.1128/AAC.45.11.3205-3208.2001.
Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.
de Mouy D, Cavallo J, Leclercq R, Fabre R
Antimicrob Agents Chemother. 2001; 45(8):2400-2.
PMID: 11451709
PMC: 90666.
DOI: 10.1128/AAC.45.8.2400-2402.2001.
Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus.
Reinscheid D, Gottschalk B, Schubert A, Eikmanns B, Chhatwal G
J Bacteriol. 2001; 183(4):1175-83.
PMID: 11157929
PMC: 94990.
DOI: 10.1128/JB.183.4.1175-1183.2001.
Epidemiology of group B streptococcal disease in the United States: shifting paradigms.
Schuchat A
Clin Microbiol Rev. 1998; 11(3):497-513.
PMID: 9665980
PMC: 88893.
DOI: 10.1128/CMR.11.3.497.
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.
Fernandez M, Hickman M, Baker C
Antimicrob Agents Chemother. 1998; 42(6):1517-9.
PMID: 9624508
PMC: 105636.
DOI: 10.1128/AAC.42.6.1517.
Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital.
Uh Y, Jang I, Yoon K, Lee C, Kwon J, Kim M
Eur J Clin Microbiol Infect Dis. 1997; 16(10):753-6.
PMID: 9405948
DOI: 10.1007/BF01709259.